The carriers of the carbohydrate differentiation antigens I, i and SSEA-1 were investigated in embryonal carcinoma cell lines of mouse and differentiated cell lines derived from them. Glycoproteins were studied by immunostaining ('Western blotting') of total cell lysates and immunoprecipitation from lysates of galactose oxidase/NaB3H4-labelled cells; glycolipids were investigated by immunostaining of thin layer chromatograms. The antigenic activities detected by immunofluorescence of cell smears were reflected in the antigenicities of high-molecular-weight glycoproteins. These were polydisperse and markedly susceptible to digestion with endo-JJ-galactosidase. Only the I antigen was detected on minor glycolipids. These observations indicate that glycoproteins rather than glycolipids are the major carriers of carbohydrate differentiation antigens I, i and SSEA-1 in the teratocarcinoma cell lines.
(Received 6 June 1983/Accepted 1 7 A ugust 1983)
The carriers of the carbohydrate differentiation antigens I, i and SSEA-1 were investigated in embryonal carcinoma cell lines of mouse and differentiated cell lines derived from them. Glycoproteins were studied by immunostaining ('Western blotting') of total cell lysates and immunoprecipitation from lysates of galactose oxidase/NaB3H4-labelled cells; glycolipids were investigated by immunostaining of thin layer chromatograms. The antigenic activities detected by immunofluorescence of cell smears were reflected in the antigenicities of high-molecular-weight glycoproteins. These were polydisperse and markedly susceptible to digestion with endo-JJ-galactosidase. Only the I antigen was detected on minor glycolipids. These observations indicate that glycoproteins rather than glycolipids are the major carriers of carbohydrate differentiation antigens I, i and SSEA-1 in the teratocarcinoma cell lines.
Studies with monoclonal antibodies have shown that a number of antigens which change during embryogenesis (termed stage specific embryonic antigens), or during the differentiation of embryonal carcinoma cells in vitro, are defined carbohydrate structures (Table 1) . These include the Forssman antigen (structure 1), the I and i antigenic determinants (structures 2-5), SSEA-1 (structure 6) and FC 10.2 (structure 7). At later stages of differentiation and maturation these antigens may diminish, disappear or become restricted to certain tissues. The function of these carbohydrate structures is not yet known. One approach to investigate this is to determine the macromolecules that carry them. The carbohydrate structures are known to occur both on glycoproteins and glycolipids of a number of mammalian cell types (Feizi, 1981; Hounsell & Feizi, 1982; Hakomori, 198 la,b; Slomiany et al., 1982; Kannagi et al., 1982; Gooi et al., 1983a,b) ; however, there is relatively little information on the macromolecules that carry them in embryos and teratocarcinomra cells. In the mouse embryonal carcinoma cell line F9, the Forssman antigen has been found associated with glycolipids (Willison et al., 1982) ; and the human embryonic antigen FC
has been shown to occur on a 200kDa
Abbreviation used: SDS, sodium dodecyl sulphate. glycoprotein in the embryonal carcinoma cell line LICR LON HT39/7 (Williams et al., 1982) and on a glycolipid in human meconium (Gooi et al., 1983b) . The carrier molecules for the Ii and SSEA-1 antigens of early mouse embryos and embryonal carcinoma cells have not, to our knowledge, been characterized, although in F9 cells SSEA-1 activity was found to be associated with macromolecules eluting from Bio-Gel columns as 500-1500 kDa aggregates (Andrews & Knowles, 1982) .
In the present studies we have assessed the expression of the I, i and SSEA-1 antigens in undifferentiated and differentiated mouse teratocarcinoma cell lines by immunofluorescence and have investigated the carrier molecules of these antigens by (a) immunostaining of total solubilized glycoproteins after electrophoresis in SDS/polyacrylamide gels, (b) immune precipitation of surface glycoproteins and (c) immunostaining of glycolipid R. A. Childs and others 1973) and MCP-6BRA (Goodfellow et al., 1982) and parietal endoderm-type cell lines derived from them, F9-AC Cl 9, cited in the text as RF9 (Solter et al., 1979) and MP-2 (Benham et al., 1983) , respectively [MCP-6BRA are hybrid cells resulting from the transfer of a human X-6 translocation chromosome (Goodfellow et al., 1982) to the mouse embryonal carcinoma cell line PCC4 (Jakob et al., 1973) 1; mouse embryonal carcinoma cell line PSA-4 (Martin & Evans, 1975 ) and a visceral endoderm-type cell line PSA-5E derived from a parallel clone (PSA-5); undifferentiated PSMB cells and two day embryoid bodies derived from PSMB . PSMB were maintained on mitomycin-inactivated feeder cells (STO mouse fibroblasts); induction of embryoid bodies was as described previously (Martin & Evans, 1975) . The other cells were cultured as monolayers at 370C in Dulbecco's minimal essential medium supplemented with 10% foetal calf serum, penicillin and streptomycin. Cells, with the exception of PSMB embryoid bodies, were detached with 0.2% EDTA in phosphate-buffered saline, pH 7.4. Contamination of PSMB cells by feeder cells was less than 1%. PSMB embryoid bodies were disaggregated with 0.25% trypsin ('trypsin 1: 250'; Difco). Cell suspensions washed with phosphate-buffered saline were used for the preparation of cell smears and the immunostaining and immunoprecipitation experiments described below.
Antibodies
The monoclonal anti-I antibodies Ma and Step and anti-i antibody Den (Table 1) from patients with cold agglutinin disease (Feizi, 1981) and the mouse hybridoma antibodies anti-SSEA-1 raised against F9 cells (Solter & Knowles, 1978; Gooi et al., 1981) and VEP8 and VEP9 raised against HL60 cell line (Rumpold et al., 1982; Gooi et al., 1983a) have been described previously. The anti-I and anti-i antibodies were used as plasma and the hybridoma antibodies as ascites fluid. Immunofluorescence Cell smears were prepared using a cytocentrifuge (Shandon, Runcorn, U.K.) and stored at -700C in the presence of silica gel. Before immunofluorescence staining, cells were fixed in acetone at 4°C for 10min. Indirect immunofluorescence was performed as described previously . The binding of anti-I and anti-i antibodies (anti-I Ma, 1: 100; anti-I Step, 1: 700 and anti-i Den, 1: 700) was detected using fluorescein-conjugated rabbit anti-human IgM (Dako, Copenhagen, Denmark) and the binding of the hybridoma antibodies anti-SSEA-1, VEP8 and VEP9 (1: 100 dilutions) was detected with fluorescein-conjugated rabbit anti-mouse immunoglobulins (Nordic, Tilburg, The Netherlands).
Immunostaining oftotal cell lysates Cells were solubilized in 2% SDS at 100°C for 5min and stored at -700C. Before electrophoresis, the following were added: 2-mercaptoethanol (3%): sucrose (5%) and Bromophenol Blue. SDS/polyacrylamide-gel electrophoresis was performed in 4-15% gradient slab gels using the conditions described by Laemmli (1970) . After SDS/polyacrylamide-gel electrophoresis, one lane was removed for staining with 0.1% Coomassie Blue in methanol/acetic acid/water (5:1:4, by vol.) and the remainder of the gel was equilibrated for 30min in 25 mM-Tris/192mM-glycine buffer, pH 8.3. Electrotransfer of proteins from gels onto nitrocellulose sheets (Bio-Rad Laboratories) was performed at 40C in Tris/glycine buffer for 2.5h at 60V. The nitrocellulose sheets were washed in 0.5 M-NaCl/ 20 mM-sodium phosphate buffer, pH 7.5 (solution A) containing 3% bovine serum albumin at 370C for 60min. The sheets were cut into strips and incubated with antibody or control serum diluted in solution A containing 3% bovine serum albumin at 40C for 14h. Antibody dilutions were: anti-i Den, 1: 1000; anti-I Ma and Step and normal human plasma, 1:300; anti-SSEA-1, VEP8 and VEP9, and normal mouse serum, 1: 100. Strips were washed twice at 40C in solution A containing 1% Triton X-100 (30min each) and once in solution A and incubated at 4°C for 3 h with either 251I-labelled rabbit immunoglobulins to human u chains or to mouse immunoglobulins. Rabbit immunoglobulins (Dako, Copenhagen, Denmark) were radiolabelled by the chloramine-T method (Greenwood et al., 1963) ; specific radioactivity was 5,uCi/ug of protein and the antibodies were used at 2 x 106 c.p.m./ ml of solution A containing 3% bovine serum albumin and 20% foetal calf serum. Strips were washed in solution A containing 1% Triton X-100 with a final rinse in solution A and air-dried. Autoradiography was performed using X-ray film obtained from Ceaverken AB, Strangras, Sweden. Use of i-and I-active glycolipids as inhibitors of the immunostaining of F9 embryonal carcinoma cell glycoproteins with anti-i Den and anti-I Ma antibodies
The i-active glycolipid lacto-N-nor-hexaosylceramide (Niemann et al., 1978) and the I-active ceramide decasaccharide (Hanfland et al., 1981) were tested as inhibitors of the immunostaining of F9 embryonal carcinoma cell glycoproteins with anti-i Den and anti-I Ma sera, respectively. These glycolipids were isolated from rabbit erythrocytes and were generously given by Dr. Peter Hanfland. For the inhibition assays each glycolipid was made into micelles with cholesterol and lecithin, as described previously . The final glycolipid concentration was 5OOpg/ml of solution A Glycoproteins as carriers of carbohydrate differentiation antigens containing 3% bovine serum albumin. This concentration of glycolipid was chosen as it was the minimum amount required for complete inhibition of binding of anti-i Den (1: 1000) and anti-I Ma (1: 300) to radiolabelled i and I-active reference glycoproteins, respectively, in a soluble phase, doubleantibody radioimmunoassay (Wood et al., 1979) .
For the inhibition of immunostaining experiments, electrotransfer of six lanes of electrophoresed F9 cell lysate onto nitrocellulose was carried out as described above. Following washing with 3% bovine serum albumin, two lanes were removed for immunostaining wtih anti-i Den and anti-I Ma sera. The remaining lanes were air-dried and stored at -700C. Using the autoradiographs of the immunostained lanes as templates, segments of the dried lanes were cut out and used for inhibition of immunostaining studies as follows: anti-i Den and anti-I Ma were pre-incubated at 40C for 60min with i-active and I-active glycolipids, respectively, and added to the segments of nitrocellulose at 40C for 14h. As a control, antibodies were preincubated with micelles of cholesterol and lecithin alone. After incubation these segments were washed and incubated with 125I-labelled rabbit anti-IgM as described above.
Endo-f/-galactosidase treatment of F9 embryonal carcinoma cell glycoproteins on nitrocellulose Electrotransfer of the SDS lysate of F9 cells from a 4-15% polyacrylamide gradient slab gel onto nitrocellulose was performed as described above. After transfer, the nitrocellulose was washed with 3% bovine serum albumin as above and incubated at 400C for 2h with an endo-fJ-galactosidase purified from B. fragilis (specific activity 150units/mg of protein) (Scudder et al., 1983a) . This enzyme cleaves internal GlcNAc(f61-3)Gal(fl1-4/3)GlcNAc-(Glc) sequences and has a similar specificity to the previously reported endo-f-galactosidase from E. freundii. The enzyme was diluted (1 unit/ml) in a solution containing 375 mmNaCl, 50mM-sodium acetate buffer, pH 5.8, and 3% bovine serum albumin. The nitrocellulose was washed in solution A and immunostained as described above.
Immunoprecipitation of radiolabelled cell-surface glycoproteins Detached cells were radiolabelled externally by the galactose oxidase/NaB3H4 method (Gahmberg & Hakomori, 1973) . Briefly, 1 x 108 cells per ml of Dulbecco's phosphate-buffered saline were treated with 0.2 units of neuraminidase/ml (from Vibrio cholerae, specific activity >20units/mg of protein;
Behringwerke AG, Marburg, Germany) and 10 units of D-galactose oxidase/ml (specific activity 714units/mg; Kabi Vitrum, Stockholm, Sweden) at 37°C for 1 h. The cells were washed with 3 x lOml of phosphate-buffered saline and labelled with 3H by the addition of 5 mCi of NaB3H4, specific radioactivity 10 Ci/mmol (The Radiochemical Centre, Amersham, Bucks., U.K.). After 30min at 18°C, the cells were washed with 6 x lOml of phosphatebuffered saline and solubilized in phosphate-buffered saline containing 1% zwitterionic detergent Empigen BB (Albright and Wilson, Whitehaven, U.K.), 2 mM-phenylmethanesulphonyl fluoride and 0.02% NaN3 and centrifuged at 2000g for 15 min to remove the unsolubilized nuclear pellet. No radioactivity was detected in the pellet. The lysates were stored at -700C and recentrifuged in a Beckman Microfuge 152 for 5min immediately before use. The supernatant, containing approx. 90% of the radioactivity of the 2000g supernatant, was used in immune precipitation experiments as follows: lOO1pu
containing 1 x 106-3 x 106 c.p.m. were incubated at 40C for 15h with antisera or ascites fluids (2Ou1 of 1: 10 dilution) followed by an excess of rabbit immunoglobulins against human u chains or mouse immunoglobulins. Immune precipitates obtained by centrifugation at 2000g for 20min were washed and solubilized as described previously (Childs & Feizi, 1981 ). An aliquot was removed for determination of radioactivity and the remainder was analysed by SDS/polyacrylamide-gel electrophoresis as described above; radiolabelled bands were visualized by fluorography at -700C (Bonner & Laskey, 1974) . Radioactivity precipitated with control normal human serum or normal mouse serum was .2% and with the antibodies up to 17% of the starting radioactivity.
Preparation ofglycolipids Lipids were extracted from 0.3-2.0ml of packed cells with 20vol. of chloroform/methanol (2:1, v/v) followed' by chloroform/methanol/water (10:10:1 and 10:20:3, by vol. Step glycolipids. The chromatograms were treated with 5% bovine serum albumin in phosphate-buffered saline for 2h and incubated at 40C for 16h with the following antibodies: anti-I Ma, anti-I Step and anti-i Den, (1:300 dilution); anti-SSEA-1 and VEP9, (1:100 dilution); and the rat monoclonal antiForssman antibody, M1/22 (Sera-Lab, Crawley Down, U.K., used without dilution). The plates were washed four times with phosphate-buffered saline, 30min each, and incubated at 40C for 4h with '25I-labelled rabbit antibodies (4 x 106c.p.m./ml) against human IgM, mouse immunoglobulins or rat immunoglobulins as appropriate. Plates were washed six times with phosphate-buffered saline (20 min each) and subjected to autoradiography (14-40h). I(Ma) antigenic determinant was expressed in the majority (greater than 80%) while i antigen was found only in sub-populations of cells in the eight embryonal carcinoma systems examined, ranging from 2% in RF9 and PSA-SE to 50% in MP-2. The finding of a sub-population of cells in the PSMB embryoid bodies with strong expression of the i antigen is in agreement with earlier observations ; these cells correspond to the primary endoderm of the early mouse embryo and are the first differentiated cells to appear in the embryoid bodies (Martin & Evans, 1975) . The positive immunofluorescence of F9 and MCP-6 cell lines with anti-SSEA-1 (Figs. 1 and 2) and the lack of staining of the parietal endoderm-type cell lines RF9 and MP-2 derived from them, confirms earlier observations (Solter et al., 1979; Benham et al., 1983) . Similarly SSEA-1 was expressed in the PSA-4 cell line but not in the visceral endoderm-type PSA-5E cell line. Undifferentiated PSMB cells behaved like 1-4 cell stage mouse embryos in their lack of expression of SSEA-1, whereas 50% of cells in the differentiating embryoid bodies derived from them acquired this antigen. Immunofluorescence with the anti-human granulocyte antibodies VEP8 and VEP9 resembled that seen with anti-SSEA-1. All of these antigens were visualized not only on the cell surface but also intracellularly, often in the form of perinuclear or granular juxtanuclear fluorescence.
The glycoprotein carriers of the I, i and SSEA-1 there was relatively little immunostaining of highmolecular-weight glycoproteins of the latter.
In agreement with the lack of immunofluorescence, SSEA-1 activity was lost or markedly reduced in the high-molecular-weight region of the differentiated cell lines RF9, MP-2 and PSA-5E (Figs.  3-5 ). This cannot be explained by a lack of high-molecular-weight glycoproteins in the differentiated cell lines since there was immunostaining of these glycoproteins with anti-I and/or anti-i antibodies. In fact, with the cell line MP-2 there was an increase in staining with the anti-I-antibodies relative to the undifferentiated MCP-6 cells (Fig. 5) .
In addition to the diffuse high-molecular-weight glycoproteins a number of discrete bands also reacted with anti-I Ma, anti-i Den, anti-SSEA-1 and the anti-granulocyte antibodies VEP8 and VEP9. With anti-I Ma and the mouse antibodies, these were numerous and they extended throughout the length of the gels but with anti-i Den there was staining of a single 54 kDa component. The majority of these bands did not differ markedly between the embryonal carcinoma and differentiated cell lines. could be specifically inhibited in the presence of I or i-active reference glycolipids (Fig. 6b) . However, the reaction of anti-I Ma with the lower-molecularweight components was not inhibited by the I-active glycolipid at a concentration of 50O0,g/ml. These observations raise the possibility that the reactions of these lower-molecular-weight components with anti-I Ma serum may be due to natural antibodies unrelated to anti-I Ma. On the other hand, they may represent I-anti-I reactions of high affinity that are difficult to inhibit in the presence of the excess antibody used for immunostaining. The amount of glycolipid required to inhibit a 1: 300 dilution of anti-I Ma was estimated in a soluble phase radioimmunoassay using a trace amount of radiolabelled, I-active, reference antigen. However, in a solid phase radioimmunoassay where the I-active, reference glycoprotein is bound to wells of plastic plates and may mimic more closely the situation of antigen bound to the nitrocellulose strip, we have observed (J. Picard & T. Feizi, unpublished work) that the amounts of inhibitor required are substantially higher (10-fold or greater).
Specific inhibition studies were not performed with the mouse antibodies anti-SSEA-1, VEP8 and VEP9. However, in experiments using control serum and ascites fluid little or no immunostaining of the polydisperse high-molecular-weight glycoproteins was observed. With normal mouse serum some bands of lower molecular weights were weakly stained but these did not correspond to the discretely migrating bands seen with the hybridoma antibodies. poly-N-acetyl-lactosamine-type which are susceptible to digestion by endo-/J-galactosidase. Treatment with this enzyme affected principally the immunostaining of high-molecular-weight glycoproteins (Fig. 6a) . Their staining with anti-i and anti-SSEA-1 was abolished and there was a substantial reduction in the immunostaining with anti-I Ma. However, there was little effect on the expression of these antigens on the discretely migrating glycoproteins. On the contrary, the decrease in the I(Ma) staining of the diffuse glycoproteins revealed numerous restricted bands in the molecular weight region of 100->200kDa. These properties may be expected of I(Ma) determinants consisting of clustered short oligosaccharides, O-glycosidically linked to protein, as in structure 4a (Table 1 ). The I(Ma) activities of such oligosaccharides would be resistant to digestion with endo-,-galactosidase (Scudder et al., 1983b) . PSA-5E the surface glycoproteins precipitating with anti-I Ma resolved into two broad bands with molecular masses of approx. 130/23OkDa (RF9), 160/27OkDa (MP-2) and 190/33OkDa (PSA-SE). Double bands were not visualized with the PSMB embryoid bodies (results not shown).
There was relatively little radioactivity in the immune precipitates with the hybridoma antibodies anti-SSEA-1, VEP8 and VEP9 and only weak polydisperse radioactive bands of high molecular weight were visualized with F9 and MCP-6 cells using anti-SSEA-1 (Figs. 3 and 5 ). This may be due to a decreased incorporation of 3H into galactose residues of glycoproteins which are rich in the oligosaccharide, Gal(fJl-4)[Fuc(al-3)IGlcNAc(fJ1-.
The paucity of glycolipids carrying the Ii and SSEA -I antigens
In contrast to the strong expression of these antigens on glycoproteins of teratocarcinoma cell Vol. 215 lines, there was little antigenic activity detectable on their glycolipids. Although the glycolipid extracts used for immunostaining were derived from 26-80-fold greater cell numbers than those used for glycoprotein analysis, there was no immunostaining with anti-i Den, anti-SSEA-1 and VEP9 and the only immunostaining detected was with anti-I Ma in the acidic glycolipids of RF9, MCP-6, MP-2 cells (Fig.  7) and in both the acidic and neutral fractions of PSA-4 cells, and with anti-I Step in the acidic fraction of MP-2 cells. As a positive control the monoclonal anti-Forssman antibody M1/22 was used with the neutral glycolipids of the F9/RF9 cell pair. As expected (Willison et al., 1982) , Forssman-active glycolipids were readily detected in the undifferentiated F9 cells.
Discussion
The immunofluorescence studies have revealed considerable heterogeneity in the expression of the I, i and SSEA-1 antigens, not only in the PSMB embryoid bodies which are known to be mixtures of undifferentiated embryonal carcinoma and primary endoderm cells, but also in the undifferentiated cell lines and the endoderm-type lines derived from them. The i antigen, which is largely associated with the primary endoderm of the early mouse embryo , is expressed to varying degrees in 2-30% of the apparently undifferentiated embryonal carcinoma cells. These i-active cells presumably correspond to the sub-populations of spontaneously differentiating cells known to occur (Sherman & Miller, 1978; Kapadia et al., 1981) in embryonal carcinoma cell lines. While none of the cell lines had immunofluorescence patterns identical with that of any specific cell type in the early mouse embryo, there were certain analogies with respect to their I, i and SSEA-1 antigenic activities. The majority of cells in the F9, MCP-6, PSA-4 lines and the PSMB embryoid bodies resemble embryo cells between the 16-cell and the early implantation stage; however, the majority of the cells of the PSMB cell line displayed no SSEA-1 antigen and resemble cells of the pre-8-cell mouse embryo Solter & Knowles, 1978) . The differentiated cell lines RF9, MP-2 and PSA-5E have antigenic characteristics (lack of SSEA-1) of a later postimplantation stage. In their strong expression of the i antigen, cells of the PSMB embryoid bodies resemble the primary endoderm of the early mouse embryo.
The immunochemical studies in this report indicate that the glycoproteins rather than glycolipids are the major carriers of the I, i and SSEA-1 antigens of the teratocarcinoma cells examined. Willison & Stern, 1978; Willison et al., 1982; Kapadia et al., 1981; (d) Feizi et al., 1982 ; (e) J. Pennington, unpublished work; (f) Gooi et al., 1981;  (g) Hounsell et al., 1981; Gooi et al., 1983a;  (I) Gooi et al., 1983b . Gal(il -3)GIcNAc(fil -3)Gal(fl -4)Glc . These glycoproteins almost certainly include the fucose-containing glycoproteins of embryos and embryonal carcinoma cells which express the antigens recognized by polyclonal anti-F9 sera (Muramatsu et al., 1979; McCormick et al., 1982) . These are also susceptible to endo-fi-galactosidase treatment (Muramatsu et al., 1979) and yield highmolecular-weight glycopeptides upon Pronase digestion. Teratocarcinomas are known to produce glycosaminoglycans (Cantor et al., 1976; Prehm, 1980; Rasilo & Renkonen, 1982) . A proportion of these are keratan-sulphate-like (Rasilo & Renkonen, 1982 ) and susceptible to endo-f,-galactosidase and might well have I, i-activities. In the differentiated cells, the high-molecular-weight double glycoprotein bands, labelled by galactose oxidase/NaB3H4 and reactive with anti-I Ma, may include the basal lamina glycoproteins that are produced by teratocarcinoma-derived differentiated cells (Chung et (Svennerholm, 1963) . & Solter, 1980; Leivo et al., 1982) . We have previously noted strong immunofluorescence of I(Ma) antigen associated with the Reicherts membrane of PSMB embryoid bodies . The promyelocytic cell line HL60 contains diffusely migrating high-molecular-weight glycoproteins which resemble those of the teratocarcinoma cells in their immunostaining reactions with the anti-i and anti-I antibodies, anti-SSEA-1, VEP8 and VEP9 (R. A. Childs & T. Feizi, unpublished work) . The monoclonal antibodies VEP8 and VEP9 were raised by immunization of mice with HL60 cells (Rumpold et al., 1982) and it is intriguing that the specificities of these two antibodies (Gooi et al., 1983a) are so closely related to that of anti-SSEA-1. The I and i antigens are expressed on a family of highmolecular-weight glycoproteins of human B lymphocytes (Childs & Feizi, 1981) ; among these are the differentiation molecules known as 'leucocyte common antigen' or T200 (Childs et al., 1983) . The corresponding glycoproteins on T lymphocytes have negligible amounts of Ii activities. Because they are such prominent structures on the cell surface and because of their different expression in lymphocytes that are functionally distinct, we have proposed (Childs et al., 1983) that the I,i-active carbohydrate structures may have receptor functions that contribute to the differing properties of T and B lymphocytes.
Our studies have shown that, apart from highmolecular-weight glycoproteins, teratocarcinoma cells contain numerous discretely migrating proteins that react with anti-I Ma and anti-i Den sera, anti-SSEA-1, VEP8 and VEP9 immune ascites. The specificities of the majority of these reactions require further investigation. The reactivity of a 54 kDa glycoprotein with anti-i Den could be inhibited in immunostaining experiments with a i-active glycolipid, although this glycoprotein was resistant to endo-f,-galactosidase. The repeating poly-N-acetyllactosamine sequence (structure 2, Table 1 ) with i-activity is usually highly susceptible to digestion with this enzyme ; however certain modifications of the sequence GIcNAc(f1-3)Gal(,81-(e.g. sulphation of galactose or al-3 fucosylation of N-acetylglucosamine) confer resistance to this enzyme (reviewed by Scudder et al., 1983a) . It is possible, therefore, that the carbohydrate chains of the 54kDa glycoprotein contain a substitution which prevents the action of the enzyme without affecting the reaction with anti-i Den.
With monoclonal antibodies to defined carbohydrate structures it is possible to study with ease the carbohydrate moieties of the same proteins in different cell types. This has recently been achieved with the high-molecular-weight glycoproteins of human T and B lymphocytes known as leucocyte common antigen (Childs & Feizi, 1981; Childs et al., 1983) . Thus the way is open for sequential studies of the carbohydrate antigens expressed on selected glycoproteins of embryonal carcinoma cells and their differentiated progeny. This would be a first step in investigating the contributions of carbohydrate structures to the functions of important glycoproteins such as the epidermal growth factor receptor and the insulin receptor, whose activities increase with the induction of differentiation (Rees et al., 1979; Heath et al., 1981) .
